Aristeia Capital’s Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock VHAQ.U Stock Holding History

Aristeia Capital’s Portfolio VHAQ.U Stock Details VHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-500,000	Closed	-$5.15M	–	520
2021 Q1	$5.15M	Hold	500,000	–	–	0.1%	253
2020 Q4	$5.13M	Buy	+500,000	New	+$5.13M	0.13%	167

Other funds holding VHAQ.U

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.58% 1-Year Est. Return

Aristeia Capital's VHAQ.U Position: Q2 2021 in Review

Aristeia Capital sold out of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) in Q2 2021, closing a stake of 500,000 shares — an estimated $5.15M sold.

Aristeia Capital first reported a position in VHAQ.U in Q4 2020 and held it in 2 quarters. The position peaked at $5.15M in Q1 2021. 15 funds tracked by Wall St. Rank hold VHAQ.U as of Q2 2021.

Aristeia Capital reported no remaining Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position as of Q2 2021 after selling out during the quarter.
Aristeia Capital sold 500,000 Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock shares in Q2 2021, an estimated $5.15M.
Aristeia Capital first reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in Q4 2020 and held it in 2 quarters.
Aristeia Capital's Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position peaked at $5.15M in Q1 2021.
15 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock as of Q2 2021.

Based on Aristeia Capital's 13F filing for Q2 2021, filed 16 Aug 2021.